Irinotecán Hospira 20 mg/mL concentrado para solución para perfusión EFG.

DRUG2 trials

Sponsors

Grupo Espanol De Tumores Neuroendocrinos, Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA

Conditions

Advanced neuroendocrine carcinomas (NECs) of the digestive system or unknown primary origin.Localised Colon Cancer (stage II-III)

Phase 2

Phase II randomized trial to assess the effect of intensive vs standard adjuvant chemotherapy in localised colon cancer with circulating tumor DNA

Not yet recruitingCTIS2024-518131-11-02

Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVALocalised Colon Cancer (stage II-III)

Target: 124Updated: 2025-01-24

Phase II Study Of Tarlatamab Alone Or In Combination With Chemotherapy In Advanced Neuroendocrine Carcinomas Of The Digestive System Or Unknown Primary Origin

RecruitingCTIS2024-514327-42-00

Grupo Espanol De Tumores NeuroendocrinosAdvanced neuroendocrine carcinomas (NECs) of the digestive system or unknown primary origin.

Start: 2025-12-18Target: 87Updated: 2025-09-12